Nirav Patel

Dr. Nirav Patel

Formulation and Process Development, Strides Pharma Inc.,, Chestnut Ridge, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2016 in Drug Delivery
Verified
Journal Article
Closed access
NPNirav Patel
Nirav Patel
HNHappy Nakrani
Happy Nakrani
MRMihir Raval
Mihir Raval
NSNavin Sheth
Navin Sheth
A novel cationic nanoemulsified in-situ ophthalmic gel of loteprednol etabonate (LE) was developed to improve the permeability and retention time of formulations for overall improvement of drug’s ocular bioavability. Capryol 90 (oil phase), tween 80 (surfactant) and transcutol P (cosurfactant) was selected as formulation excipients to construct pseudoternary phase diagrams and nanoemulsion region was recognized from diagrams. Spontaneous emulsification method was used to manufacture LE nanoemulsion and it was optimized using 32 factorial design by considering the amount of oil and the ratio of surfactant to cosurfactant (Smix) as independent variables and evaluated for various physicochemical properties. Optimized NE was dispersed in Poloxamer 407 and 188 solution to form nanoemulsified sols that were predictable to transform into in-situ gels at corneal temperature. Drug pharmacokinetics of sterilized optimized in situ NE gel, NE-ISG2 [0.69% w/w Capryol 90, 0.99%w/w Smix (3:1), 13% Poloxamer 407, 4% w/w Poloxamer 188] and marketed formulation were assessed in rabbit aqueous humor. The in-situ gels were clear, shear thinning in nature and displayed zero-order drug release kinetics. NE-ISG2 showed the minimum ocular irritation potential and significantly (p < 0.01) higher Cmax and AUC(0–10 h), delayed Tmax, extended mean residence time and improved (2.54-fold times) bioavailability compared to marketed formulation.

29 January 2016 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDF file
NPNirav Patel
Nirav Patel
Vaishali ThakkarVaishali Thakkar
Vaishali Thakkar
VMViral Metalia
Viral Metalia
LBLalji Baldaniya
Lalji Baldaniya
TGTejal Gandhi
Tejal Gandhi
MGMukesh Gohel
Mukesh Gohel
Context: The conventional liquid ophthalmic delivery systems exhibit short precorneal residence time and the relative impermeability to the cornea which leads to poor ocular bioavailability. Objective: The aim of this study was to apply quality by design (QbD) for development of Dexamethasone sodium phosphate (DSP) and Tobramycin sulphate (TS) loaded thermoresponsive ophthalmic In Situ gel containing poloxamer 407 and Hydroxyl propyl methyl cellulose (HPMC) K4M for prolonging the pre-corneal residence time, ocular bioavability and decreases the frequency of administration of dosage form. The material attributes and the critical quality attributes (CQA) of the in-situ gel were identified. Central composite design (CCD) was adopted to optimize the formulation. Materials and methods: The ophthalmic In Situ forming gels were prepared by cold method. Materials attributes were the amount of poloxamer 407 and HPMC and CQA identified were Gel strength, mucoadhesive index, gelation temperature and % of dru...

1 January 2016 in International Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
NPNirav Patel
Nirav Patel
VTVaishali Thakkar
Vaishali Thakkar
VKVaishali Korat
Vaishali Korat
LBLalji Baldaniya
Lalji Baldaniya
MGMukesh Gohel
Mukesh Gohel
TGTejal Gandhi
Tejal Gandhi
Introduction: The aim of burn management and therapy is fast healing and epithelisation to prevent infection. The present study is concerned with the development and characterization of a novel nanaoparticulate system; cubosomes, loaded with silver sulfadiazine (SSD) and Aloe vera for topical treatment of infected burns. Methods: Cubosome dispersions were formulated by an emulsification technique using different concentrations of a lipid phase Glyceryl Monooleate (GMO) and Poloxamer 407. The optimum formulae were incorporated in an aloe vera gel containing carbopol 934, to form cubosomal hydrogels (cubogels). The cubogels were characterized by in vitro release of SSD, rheological properties, pH, bioadhesion, Transmission Electron Microscopy and in-vivo Wound Healing Study. Results: The results show that the different concentration of GMO had significant effect on particle size, % EE and in vitro drug release. From the in-vitro drug release pattern and similarity factor (f2), it was concluded that batch CG3 (15% GMO and 1% P407) exhibited complete and controlled drug release within 12 hour (i.e. 98.25%), better bio adhesion and superior burn healing as compared to the marketed product. Conclusion: The in vivo burns healing study in rats revealed that the prepared optimized cubogel containing SSD and aloe vera has superior burns healing rate than cubogel with only SSD and marketed preparation so, it may be successfully used in the treatment of deep second degree burn.

1 January 2008 in Dissolution Technologies
Verified
Journal Article
Closed access
NPNirav Patel
Nirav Patel
NCNarendra Chotai
Narendra Chotai
JPJayvadan Patel
Jayvadan Patel
TSTejal Soni
Tejal Soni
JDJulan Desai
Julan Desai
RPRajanikant C Patel
Rajanikant C Patel

1 October 2015 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
NPNirav Patel
Nirav Patel
Vaishali ThakkarVaishali Thakkar
Vaishali Thakkar
PMParita Moradiya
Parita Moradiya
TGTejal Gandhi
Tejal Gandhi
MGMukesh Gohel
Mukesh Gohel

9 March 2016 in Journal of Pharmaceutical Investigation
Verified
Journal Article
Closed access
PDF file
NPNirav Patel
Nirav Patel
NPNiyati Padia
Niyati Padia
NVNeha Vadgama
Neha Vadgama
MRMihir Raval
Mihir Raval
NSNavin Sheth
Navin Sheth